<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1403233370
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2023
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Tekam
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        KETAMINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intramuscular and intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection/infusion
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Controlled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        104.20
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Hikma Farmaceutica" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Hikma Farmaceutica
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 612]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Abdulrehman Algosaibi G.T.C.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jazeera Pharmaceutical Industries (JPI)	
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        QN01AX03
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine contains ketamine hydrochloride which belongs to a group of medicines called anaesthetic agents, which are used to put you to sleep during an operation. Tekam may be used in both routine and emergency surgery.</p><p>Tekam is used in adults, the elderly and children. Tekam can be given alone or in combination with other anaesthetic agents.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>You should not be given Tekam:</strong></p><ul><li>If you are allergic to ketamine hydrochloride or any of the other ingredients of this medicine (listed in section 6).</li><li>If you are suffering from any condition in which an increase in blood pressure may be harmful to you or have suffered in the past from a medical condition which may have been caused/made worse by an increase in blood pressure.</li><li>If you have been pregnant and during your pregnancy you have suffered from a condition called eclampsia or pre-eclampsia which causes an increase in your blood pressure.</li><li>If you have recently suffered a stroke or serious head or brain injury.</li><li>If you have severe heart disease.</li><li>If you are pregnant, trying to become pregnant or breast-feeding. However, ketamine may safely be used in caesarean section surgery or vaginal delivery.</li></ul><p><strong>Warnings and precautions</strong><br />Talk to your doctor or nurse if any of the following apply to you, to help them decide if Tekam is suitable for you. If you:</p><ul><li>Drink large amounts of alcohol</li><li>Have a history of drug abuse or addiction</li><li>Have a history of or have current mental health problems</li><li>Have a chest infection or problems breathing</li><li>Have problems with your liver</li><li>Have increased pressure in the eye (glaucoma)</li><li>Have an inherited disease that affects the blood (porphyria)</li><li>Have ever had seizures</li><li>Are receiving treatment for your thyroid gland</li><li>Have had any injury to your head or abnormal growth in the brain</li></ul><p>If before your operation the pressure in your spinal cord is raised, your anaesthetist will pay special attention to this during the operation.</p><p>Ketamine administration is associated with hepatobiliary dysfunction (most often a cholestatic pattern) with recurrent use. (e.g., misuse/abuse or medically supervised unapproved indications). Biliary duct dilatation with or without evidence of biliary obstruction has also been reported with recurrent use.</p><p>The doctor will obtain baseline liver function tests, including alkaline phosphatase and gamma glutamyl transferase, in patients receiving ketamine as part of a treatment plan that utilizes recurrent dosing. The doctor will monitor those receiving recurrent ketamine at periodic intervals during treatment.</p><p><strong>Other medicines and Tekam</strong><br />Tell your doctor if you are taking, have recently taken or might take any other medicines.</p><p>Ketamine is usually given together with other medicines during surgery.</p><ul><li>Tell your doctor if you are taking barbiturates (e.g. thiopental) and narcotics (morphine-like drugs) since use with ketamine may slow your recovery from anaesthesia. Otherwise, ketamine may be used with all other general and local anaesthetics.</li><li>Diazepam can increase the effects of Tekam so dose adjustments may be needed.</li><li>Using sympathomimetics (for example adrenaline or noradrenaline) or vasopressin with Tekam may lead to an increase in blood pressure and heart rate.</li><li>Using Tekam with ergometrine may lead to an increase in blood pressure.</li><li>Using Tekam with theophylline or aminophylline may lead to an increased likelihood of seizures.</li><li>Concomitant use of medicines used to treat high blood pressure carries the risk of developing hypotension (low blood pressure).</li><li>When given to patients already on thyroid hormone tablets, there is an increased risk of developing a fast heart rate and high blood pressure.</li></ul><p><strong>Tekam with food and drink</strong><br />It is normal not to eat or drink for at least six hours before an operation; therefore ketamine is usually given when your stomach is empty. If in an emergency, this is not possible, ketamine may still be used.</p><p><strong>Pregnancy and breast-feeding</strong><br />If you are pregnant or breast-feeding<strong>, </strong>think you may be pregnant or are planning to have a baby, ask your doctor for advice before being given this medicine.</p><p><strong>Driving and using machines</strong><br />Caution should be taken when driving or operating machines following treatment with Tekam. You should not drive or operate machines in the first 24 hours after your operation.</p><p>The medicine can affect your ability to drive as it may make you sleepy or dizzy.</p><ul><li>Do not drive while taking this medicine until you know how it affects you.</li><li>It is an offence to drive if this medicine affects your ability to drive.</li><li>However, you would not be committing an offence if:<ul><li>The medicine has been prescribed to treat a medical or dental problem and</li><li>You have taken it according to the instructions given by the prescriber or in the information provided with the medicine and</li><li>It was not affecting your ability to drive safely</li></ul></li></ul><p>Talk to your doctor or pharmacist if you are not sure whether it is safe for you to drive while taking this medicine.</p><p><strong>Tekam<strong> </strong>contains sodium</strong><br />Tekam contains sodium. Each 20 ml of Tekam 200 mg/20 ml Solution for Injection/Infusion contains 59.11 mg sodium (main component of cooking/table salt). This is equivalent to 2.95% of the recommended maximum daily dietary intake of sodium for an adult.</p><p>Tekam contains sodium. Each 10 ml of Tekam 500 mg/10 ml Solution for Injection/Infusion contains 6.21 mg sodium. This medicine contains less than 1 mmol sodium (23 mg) per 10 ml, that is to say essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <ul><li>Except in an emergency, ketamine should only be used in hospitals by experienced anaesthetists with resuscitation equipment available.</li><li>Before your operation you will usually be given a medicine such as atropine or hyoscine to dry up your secretions (body fluids like saliva and tears) and another medicine called a benzodiazepine. The benzodiazepine will help you to relax and help to prevent a side effect known as &quot;emergence reaction&quot;.</li><li>The dose of ketamine depends on its use and varies from person to person. When injected directly into a vein at a dose of 2 mg for every kg of your bodyweight, ketamine produces unconsciousness within 30 seconds and this lasts for 5 to 10 minutes. Because it works so quickly, it is important to be lying down, or supported in some other way when the drug is given. When ketamine is injected into a muscle, at a dose of 10 mg for every kg of bodyweight, it takes longer to work (3 to 4 minutes) but lasts 12 to 25 minutes.</li><li>Your anaesthetist will then keep you anaesthetised with either:<ul style="margin-left:40px"><li>Another anaesthetic</li><li>More ketamine given by injection into a muscle or vein, or in a drip (infusion)</li><li>Ketamine together with another anaesthetic.</li></ul></li><li>When it is injected directly into a vein, ketamine is given over at least a minute so that it does not slow your breathing too much. If breathing is slowed, it can be helped mechanically.</li><li>While you are anaesthetised, your anaesthetist will watch over you constantly, paying particular attention to your breathing, airways, reflexes, the degree of anaesthesia and the condition of your heart.</li><li>You should not be released from hospital until you have completely recovered from the anaesthetic. If you are discharged on the same day as the operation, you should be accompanied by another adult (see also the section on &lsquo;Driving and using machines&rsquo;).</li></ul><p><strong>If you are given more Tekam<strong> </strong>than you should</strong><br />If you are given more Tekam than you should<strong> </strong>you may experience breathing difficulties. Your doctor or nurse may provide you with equipment to help you breath.</p><p>If you have any further questions on the use of this medicine, ask your doctor or nurse.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects although not everyone gets them.</p><p>Tell your doctor immediately<strong> </strong>if you notice pain, inflammation of the skin or rash at the injection site.</p><p>Ketamine can sometimes cause allergic symptoms (&lsquo;anaphylaxis&rsquo;) such as breathing problems, swelling and rash. Some people have hallucinations, vivid dreams, nightmares, feel ill at ease, confused, anxious or behave irrationally while recovering from anaesthesia with ketamine. These side effects are collectively known as an &lsquo;emergence reaction&rsquo;. You will be allowed to recover from the anaesthetic in a quiet place and this helps to prevent the reaction (see section 3 under &lsquo;How Tekam is given&rsquo;).</p><p><strong>Common: may affect up to 1 in 10 people</strong></p><ul><li>The following, while recovering from anaesthesia (these are collectively known as an &lsquo;emergence reaction&rsquo;): hallucinations (which may include flashbacks or floating sensation), vivid dreams, nightmares, feeling ill at ease, confused, anxious and irrational behaviour.</li><li>Unusual eye movements, increased muscle tone and muscle twitches (which may resemble &lsquo;fits&rsquo; or convulsions).</li><li>Double vision.</li><li>Increased blood pressure and increased pulse rate.</li><li>Breathing more quickly.</li><li>Nausea, vomiting.</li><li>Skin inflammation/rash.</li></ul><p><strong>Uncommon: may affect up to 1 in 100 people </strong></p><ul><li>Loss of appetite, feeling anxious.</li><li>Slowing of heart rate, changes in heart rhythm.</li><li>Lowering of blood pressure.</li><li>Breathing more slowly, narrowing of the voice-box leading to difficulty in breathing.</li><li>Pain, inflammation of the skin or rash at the injection site.</li></ul><p><strong>Rare: may affect up to 1 in 1000 people </strong></p><ul><li>Allergic symptoms (&lsquo;anaphylaxis&rsquo;) such as breathing problems, swelling and rash.</li><li>Drifting in and out of consciousness (with feeling of confusion and hallucinations), flashbacks, feeling ill at ease, sleeplessness, feeling disorientated.</li><li>Effect on the reflexes which keep your airways clear, resulting in temporary inability to breathe.</li><li>Increase in salivation.</li><li>Inflammation of the bladder and/or pain when urinating (&lsquo;cystitis&rsquo;). The appearance of blood in the urine may also occur.</li></ul><p><strong>Not known: frequency cannot be estimated from the available data </strong></p><ul><li>Raised pressure in the eyes.</li><li>Abnormal results to liver function tests.</li><li>Drug-induced liver injury (when taken for more than 3 days).</li><li>Hepatobiliary dysfunction and biliary duct dilatation.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Store below 30&deg;C. Avoid freeze.</p><p>Store in the original package in order to protect from light.</p><p>Do not use this medicine after the expiry date which is stated on the package after &ldquo;EXP&rdquo;. The expiry date refers to the last day of that month.</p><p>Do not use this medicine if you notice any visible signs of deterioration.</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is ketamine hydrochloride.</p><p>Each 20 ml of Tekam 200 mg/20 ml Solution for Injection/Infusion contains 230.6 mg ketamine hydrochloride equivalent to 200 mg ketamine.</p><p>Each 10 ml of Tekam 500 mg/10 ml Solution for Injection/Infusion contains 576.7 mg ketamine hydrochloride equivalent to 500 mg ketamine.</p><p>The other ingredients are benzethonium chloride, sodium chloride and water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Tekam 200 mg/20 ml Solution for Injection/Infusion is a clear colourless solution in 20 ml amber glass vials sealed with colorless flip-off caps. 

Pack size: 10 Vials (20 ml).

Tekam 500 mg/10 ml Solution for Injection/Infusion is a clear colourless solution in 10 ml amber glass vials with dark brown flip-off caps. 

Pack size: 1 Vial (10 ml). 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorization Holder</strong><br />Jazeera Pharmaceutical Industries<br />Al-Kharj Road<br />P.O. Box 106229<br />Riyadh 11666, Saudi Arabia<br />Tel: + (966-11) 8107023, + (966-11) 2142472<br />Fax: + (966-11) 2078170<br />e-mail: SAPV@hikma.com</p><p><strong>Manufacturer</strong><br />Hikma Farmaceutica (Portugal), S.A.<br />Estrada do Rio Da M&oacute;,<br />n.&deg;8, 8A e 8B, Ferven&ccedil;a<br />2705-906 Terrugem<br />Sintra, Portugal<br />Tel: + (351-2) 19608410<br />Fax: + (351-2) 19615102</p><p><strong>Reporting of side effects</strong><br />If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below). By reporting side effects, you can also help provide more information on the safety of this medicine.</p><ul><li>Saudi Arabia</li></ul><p>The National Pharmacovigilance Centre (NPC)<br />SFDA Call Center: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa</p><ul><li>Other GCC States</li></ul><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 10/2023; version number SA5.0
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">يحتوي هذا الدواء على هيدروكلوريد الكيتامين الذي ينتمي إلى مجموعة الأدوية التي تسمى مواد التخدير، والتي تُستخدم لإدخالك في النوم أثناء العملية. يمكن استخدام دواء تيكام في كل من الجراحة الروتينية والطارئة.</p><p dir="RTL">يستخدم تيكام لدى البالغين، كبار السن والأطفال. يمكن إعطاء تيكام وحده أو مع مواد تخدير أخرى.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>يجب عدم إعطائك تيكام</strong><strong>:</strong></p><ul dir="rtl"><li>إذا كنت تعاني من حساسية لهيدروكلوريد الكيتامين أو لأي من المواد الأخرى المستخدمة في تركيبة هذا الدواء (المذكورة في القسم 6).</li><li>إذا كنت تعاني من أي حالة قد يضر بها ارتفاع ضغط الدم لديك أو إذا كنت قد عانيت في الماضي من حالة طبية نجمت عن أو ساءت بسبب ارتفاع ضغط الدم لديك.</li><li>إذا كنتِ حاملاً في السابق وعانيت أثناء حملك من حالة تسمى الارتعاج أو مقدمة الارتعاج التي تسبب زيادة في ضغط الدم.</li><li>إذا عانيت مؤخرًا من سكتة دماغية أو إصابة خطيرة في الرأس أو الدماغ.</li><li>إذا كنت تعاني من مرض شديد في القلب.</li><li>إذا كنتِ حاملاً، تحاولين الانجاب أو ترضعين طبيعيًا. ومع ذلك، قد يُستخدم دواء كيتامين بأمان في جراحة العملية القيصرية أو الولادة الطبيعية.<strong>&nbsp;</strong></li></ul><p dir="RTL"><strong>الاحتياطات والتحذيرات</strong><br />تحدث مع طبيبك أو الممرض إذا انطبقت عليك أي من الحالات التالية لتساعدهما على تحديد ما إذا كان يناسبك تيكام إذا كنت:</p><ul dir="rtl"><li>تشرب كميات كبيرة من الكحول</li><li>تعاني سابقاً من سوء استخدام الدواء أو الإدمان عليه</li><li>تعاني من مشاكل صحية ذهنية أو كنت تعاني منها حاليًا</li><li>تعاني من عدوى في الصدر أو مشاكل في التنفس</li><li>تعاني من مشاكل في الكبد</li><li>تعاني من ارتفاع ضغط العين (الزرق)</li><li>تعاني من مرض موروث يؤثر على الدم (البرفيرية)</li><li>قد عانيت مسبقًا من نوبات صرعية</li><li>تتلقى علاجًا للغدة الدرقية</li><li>قد عانيت سابقاً من أي إصابة في الرأس أو نمو غير طبيعي في الدماغ</li></ul><p>إذا ارتفع الضغط داخل الحبل النخاعي لديك قبل إجراء عمليتك، فسيولي طبيب التخدير عناية خاصة لهذا الأمر أثناء إجراء العملية.</p><p dir="RTL">يرتبط الاستعمال المتكرر لكيتامين بضعف الكبد الصفراوي (غالباً على شكل الركود الصفراوي). (مثل الاستعمال الخاطئ/ المتكرر أو الاستعمالات غير الموافق عليها طبياً). تم الإبلاغ عن توسع القناة الصفراوية مع الاستعمال المتكرر مع وجود أو بدون وجود دليل على حدوث انسداد القناة الصفراوية.</p><p dir="RTL">سوف يقوم الطبيب بالحصول على فحوصات وظائف الكبد الأساسية وتشمل الفوسفاتاز القلوي وناقلة الببتيد غاما غلوتاميل عند المرضى الذين يتناولون كيتامين كجزء من خطة العلاج ويستخدمون جرعات متكررة. سوف يقوم الطبيب بمراقبة أولئك الذين يتناولون كيتامين بشكل دوري خلال العلاج.</p><p><strong>&nbsp;الأدوية الأخرى وتيكام</strong><br />أخبر طبيبك إذا كنت تأخذ، أخذت مؤخرًا، أو قد تأخذ أية أدوية أخرى.</p><p>عادة ما يُعطى كيتامين مع أدوية أخرى أثناء إجراء الجراحة.</p><ul dir="rtl"><li>أبلغ طبيبك إذا كنت تتناول الباربيتورات (مثل ثَيُوبينتال) والمخدرات (أدوية تشبه المورفين) حيث إن استخدامهما بالتزامن مع كيتامين قد يبطئ من استرداد الوعي من التخدير. وخلافًا لذلك، يمكن استخدام كيتامين مع جميع مواد التخدير العامة والموضعية الأخرى.</li><li>يمكن لديازيبام أن يزيد تأثير تيكام لذا يمكن أن تكون هناك حاجة لتعديل الجرعة.</li><li>يمكن أن يؤدي استخدام أدوية محاكية الودية (على سبيل المثال الأدرينالين أو النورأدرينالين) أو فازوبريسين مع تيكام إلى زيادة في ضغط الدم ومعدل نبضات القلب.</li><li>يمكن أن يؤدي استخدام تيكام مع إيرغوتامين إلى زيادة في ضغط الدم.</li><li>يمكن أن يؤدي استخدام تيكام مع ثيوفيلين أو أمينوفيلين إلى زيادة احتمالية حدوث نوبات صرعية.</li><li>يحمل الاستخدام المتزامن مع الأدوية المستخدمة لعلاج ارتفاع ضغط الدم خطر حصول انخفاض ضغط الدم (ضغط الدم المنخفض).</li><li>عند إعطائه لمرضى يتناولون مسبقاً أقراص هرمون الثايرويد، يوجد خطر متزايد للإصابة بتسارع نبض القلب وارتفاع ضغط الدم.</li></ul><p><strong>تيكام مع الطعام والشراب</strong><br />من الطبيعي الامتناع عن الأكل أو الشرب لمدة ست ساعات على الأقل قبل إجراء العملية؛ ولذلك عادةً ما يُعطى كيتامين عندما تكون المعدة فارغة. في الحالات الطارئة، يكون الامتناع عن الأكل غير ممكن ولكن يبقى استخدام كيتامين ممكناً.</p><p><strong>الحمل والرضاعة</strong><br />إذا كنت حاملاً أو مرضع، تعتقدين بأنك حامل أو تخططين لذلك يرجى استشارة طبيبك قبل أن يتم إعطاؤك هذا الدواء.</p><p><strong>القيادة واستخدام الآلات</strong><br />يجب توخِي الحذر عند القيادة أو تشغيل الآلات بعد العلاج بتيكام. يجب عليك عدم القيادة أو تشغيل الآلات خلال الـ 24 ساعة الأولى بعد إجراء عمليتك.</p><p>قد يؤثر الدواء على قدرتك على القيادة حيث إنه قد يجعلك تشعر بالنعاس أو الدوخة.</p><ul dir="rtl"><li>لا تقم بالقيادة أثناء استخدام هذا الدواء حتى تعرف مدى تأثيره عليك.</li><li>تُعد القيادة تحت تأثير هذا الدواء جريمة إذا كان هذا الدواء يؤثر على قدرتك على القيادة.</li><li>ومع ذلك، لا يعد تناوله جريمة في الحالات التالية:<ul><li>إذا تم وصف الدواء لعلاج مشكلة طبية أو مشكلة متعلقة بالأسنان و</li><li>في حال استخدامه وفقًا لتعليمات الطبيب الذي وصفه لك أو وفقًا للمعلومات المتوفرة مع الدواء و</li><li>إذا كان هذا الدواء لا يؤثر على قدرتك على القيادة بأمان</li></ul></li></ul><p>تحدث إلى طبيبك أو الصيدلي إذا كنت غير متأكد حول ما إذا كانت القيادة آمنة لك أثناء استخدام هذا الدواء.</p><p><strong>يحتوي تيكام على الصوديوم</strong><br />يحتوي تيكام على الصوديوم. تحتوي كل 20 مللتر من تيكام 200 ملغم/20 مللتر محلول للحقن/للتسريب على 59,11 ملغم صوديوم (المكون الرئيسي للطبخ/ملح الطعام). هذا يكافئ 2.95% من الحد الأقصى الموصى به من الحصة الغذائية اليومية من الصوديوم للبالغين.</p><p dir="RTL">&nbsp;يحتوي تيكام على الصوديوم. تحتوي كل 10 مللتر من تيكام 500 ملغم/10 مللتر محلول للحقن/للتسريب على 6,21 ملغم صوديوم. يحتوي هذا الدواء على أقل من 1 ملمول صوديوم (23 ملغم) لكل 10 مللتر، وبذلك يعتبر &rsquo;خالٍ من الصوديوم&lsquo; بشكل أساسي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <ul dir="rtl"><li>باستثناء الحالات الطارئة، يجب استخدام كيتامين في المستشفيات فقط وتحت إشراف أطباء التخدير المتمرسين مع توفر أجهزة الإنعاش.</li><li>قبل إجراء عمليتك ستُعطى في العادة دواءً مثل أتروبين أو هيوسين لتجفيف إفرازاتك (السوائل الجسدية مثل اللعاب والدموع) ودواءً آخراً يسمى بنزوديازيبين. سيساعدك البنزوديازيبين على الاسترخاء ومنع ظهور أثر جانبي معروف باسم &quot;ظاهرة الصحو من التخدير&quot;.</li><li>تعتمد جرعة كيتامين على الهدف من استخدامه وتختلف من شخص إلى آخر. عند حقنه مباشرة في أحد الأوردة بجرعة 2&nbsp;ملغم لكل كغم من وزن الجسم، يسبب كيتامين فقدان الوعي خلال 30 ثانية ويستمر المفعول لمدة 5 إلى 10 دقائق. بسبب مفعوله السريع جدًا، من المهم أن تكون مستلقيًا أو مسنودًا بطريقة ما عند إعطائك الدواء. عند حقن كيتامين في عضلة ما، بجرعة 10&nbsp;ملغم لكل كغم من وزن الجسم، يستغرق بدء المفعول مدة أطول (3&nbsp;إلى 4&nbsp;دقائق) ولكن يستمر من 12&nbsp;إلى 25&nbsp;دقيقة.</li><li>سيبقيك طبيب التخدير في ذلك الوقت مخدَّرًا باستخدام أي مما يلي:<ul><li>مخدر آخر</li><li>حقنك بالمزيد من كيتامين في عضلة أو وريد أو بالتقطير (التسريب)</li><li>إعطاء كيتامين مع مخدِّر آخر.</li></ul></li><li>عند حقنه مباشرة في أحد الأوردة، يُعطى كيتامين على مدى دقيقة على الأقل حتى لا يبطئ عملية تنفسك بشكل كبير. إذا أصبح التنفس بطيئًا، فيمكن مساندة التنفس ميكانيكياً.</li><li>بينما أنت مخدر، سيراقب طبيب التخدير حالتك باستمرار، مراعيًا بشكل خاص تنفسك، المسالك الهوائية، الاستجابات، درجة التخدير وحالة قلبك. &nbsp;</li><li>يجب ألا تخرج من المستشفى إلا بعد استرداد الوعي التام من المخدر. إذا خرجت في يوم العملية نفسه، فيجب أن يرافقك شخص بالغ آخر (انظر أيضًا إلى قسم &rsquo;القيادة واستخدام الآلات&lsquo;).</li></ul><p dir="RTL"><strong>إذا أُعطيت تيكام أكثر من اللازم</strong><br />إذا أُعطيت جرعة زائدة من تيكام قد تعاني من مشاكل في التنفس. قد يزودك طبيبك أو الممرض بجهاز لمساعدتك على التنفس.</p><p>إذا كانت لديك أي أسئلة إضافية حول استخدام هذا الدواء، استشر طبيبك أو الممرض.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثل جميع الأدوية، قد يسبب هذا الدواء آثاراً جانبية، إلا أنه ليس بالضرورة أن تحدث لدى جميع مستخدمي هذا الدواء.</p><p>أخبر طبيبك فوراً إذا لاحظت ألمًا، التهابًا جلدياً أو طفحًا في موضع الحقن.</p><p>يمكن أن يسبب كيتامين أحيانًا أعراضًا تحسسية (&rsquo;التأق&lsquo;) مثل مشاكل التنفس، التورم والطفح. يعاني بعض الناس من الهلوسات، الأحلام الحية، الكوابيس، الشعور بالمرض لأي سبب، الارتباك، التوتر أو التصرف بغير عقلانية أثناء استرداد الوعي من المخدر باستخدام كيتامين. وتعرف هذه الآثار الجانبية كلها بـ &rsquo;ظاهرة الصحو من التخدير&lsquo;. سُيسمح لك باسترداد الوعي من المخدر في مكان هادئ حيث يساعد هذا الأمر في منع حدوث رد الفعل هذا (انظر قسم 3&nbsp;تحت &rsquo;طريقة إعطائك تيكام&lsquo;).</p><p><strong>شائعة: قد تؤثر فيما يصل إلى شخص واحد من كل 10 أشخاص </strong></p><ul dir="rtl"><li>الحالات التالية، أثناء استرداد الوعي من المخدر (تُعرف كلياً باسم &rsquo;ظاهرة الصحو من التخدير&lsquo;): هلوسات (التي قد تتضمن الارتجاعات الذهنية أو الإحساس بالعوم)، الأحلام الحية، الكوابيس، الشعور بالمرض لأي سبب، الارتباك، التوتر والتصرف بغير عقلانية. &nbsp;</li><li>حركات غير عادية للعين، ازدياد توتر العضلات وتشنجات العضلات (التي قد تشبه &rsquo;النوبات&lsquo; أو &rsquo;الاختلاجات&lsquo;).</li><li>ازدواجية الرؤية.</li><li>ارتفاع ضغط الدم وزيادة معدل النبض.</li><li>التنفس بسرعة أكبر.</li><li>غثيان، قيء.</li><li>التهاب الجلد/الطفح الجلدي.</li></ul><p><strong>غير شائعة: قد تؤثر فيما يصل إلى شخص واحد من كل 100 شخص </strong></p><ul dir="rtl"><li>فقدان الشهية، الشعور بالقلق.</li><li>بطء معدل نبضات القلب، حدوث تغيرات في نبضات القلب.</li><li>انخفاض ضغط الدم.</li><li>التنفس ببطء أكبر، ضيق الحنجرة مما يؤدي إلى صعوبة في التنفس.</li><li>ألم، التهاب جلدي أو طفح في موضع الحقن.</li></ul><p dir="RTL"><strong>نادرة: قد تؤثر فيما يصل إلى شخص واحد من كل 1000 شخص </strong></p><ul dir="rtl"><li>أعراض تحسسية (&rsquo;التأق&lsquo;) مثل مشاكل التنفس، التورم والطفح.</li><li>الدخول في حالة الوعي والخروج منها (مع الشعور بالارتباك والهلوسات)، الارتجاعات الذهنية، الشعور بالمرض لأي سبب، الأرق، التوهان.</li><li>تؤثر على الاستجابات التي تحافظ على جلاء المسالك الهوائية، مما تؤدي إلى عدم قدرة على التنفس بشكل مؤقت.</li><li>زيادة في إفراز اللعاب.</li><li>التهاب المثانة و/أو ألم أثناء التبول (&rsquo;التهاب المثانة&lsquo;). قد يحدث أيضًا ظهور دم في البول.</li></ul><p><strong>غير معروفة: لا يمكن تقدير تكرارها من البيانات المتوفرة </strong></p><ul dir="rtl"><li>ارتفاع الضغط في العينين.</li><li>نتائج غير طبيعية لفحوصات وظائف الكبد.</li><li>إصابة الكبد الناجمة عن الدواء (عند استخدامه لأكثر من 3 أيام).</li><li>ضعف الكبد الصفراوي وتوسع القناة الصفراوية.</li></ul>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ هذا الدواء بعيداً عن مرأى ومتناول الأطفال.</p><p dir="RTL">يحفظ عند درجة حرارة أقل من 30&deg; مئوية. تجنب التجميد.</p><p dir="RTL">يحفظ داخل العبوة الأصلية للحماية من الضوء.</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المذكور على العبوة الخارجية بعد &quot;EXP&quot;. يشير تاريخ انتهاء الصلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">لا تستخدم هذا الدواء إذا لاحظت أي علامات تلف واضحة عليه.</p><p dir="RTL">لا تتخلص من أي أدوية عن طريق مياه الصرف الصحي أو النفايات المنزلية. اسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. هذه الإجراءات ستساعد في الحفاظ على سلامة البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي هيدروكلوريد الكيتامين.</p><p>تحتوي كل 20 مللتر من تيكام 200 ملغم/20 مللتر محلول للحقن/للتسريب على 230.6 ملغم هيدروكلوريد الكيتامين يكافئ 200 ملغم كيتامين.</p><p>تحتوي كل 10 مللتر من تيكام 500 ملغم/10 مللتر محلول للحقن/للتسريب على 576.7 ملغم هيدروكلوريد الكيتامين يكافئ 500 ملغم كيتامين.</p><p dir="RTL">المواد الأخرى المستخدمة في التركيبة التصنيعية هي كلورید البنزیثونیوم، كلورید الصودیوم وماء معد للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تيكام 200 ملغم/20 مللتر محلول للحقن/للتسريب هو محلول صافٍ عديم اللون في زجاجات كهرمانية بحجم 20 مللتر مغلقة بأغطية عديمة اللون قابلة للفتح لأعلى.</p><p dir="RTL">حجم العبوة: 10 زجاجات (20 مللتر).</p><p dir="RTL">تيكام 500 ملغم/10 مللتر محلول للحقن/للتسريب هو محلول صافٍ عديم اللون في زجاجات كهرمانية بحجم 10 مللتر مغلقة بأغطية ذات لون بني غامق قابلة للفتح لأعلى.</p><p>حجم العبوة: زجاجة واحدة (10 مللتر).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>مالك رخصة التسويق</strong><br />شركة الجزيرة للصناعات الدوائية<br />طريق الخرج<br />صندوق بريد 106229<br />الرياض 11666، المملكة العربية السعودية<br />هاتف: 8107023 (11-966) +، 2142472 (11-966) +<br />فاكس: 2078170 (11-966) +<br />البريد الإلكتروني: SAPV@hikma.com</p><p dir="RTL"><strong>الشركة المصنعة</strong><br />شركة أدوية الحكمة (البرتغال)، المساهمة العامة المحدودة<br />إسترادا دو ريو دا مو،<br /><img alt="" width="160" height="18" src="data:image/png;base64,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" /><br />2705-906 تيروجيم<br />سنترا، البرتغال<br />هاتف: 19608410 (2-351) +<br />فاكس: 19615102 (2-351)</p><p><strong>للإبلاغ عن الآثار الجانبية</strong><br />تحدث إلى الطبيب، الصيدلي، أو الممرض إذا عانيت من أية آثار جانبية. وذلك يشمل أي آثار جانبية لم يتم ذكرها في هذه النشرة. كما أنه يمكنك الإبلاغ عن هذه الآثار مباشرةً (انظر التفاصيل المذكورة أدناه(. من خلال الإبلاغ عن الآثار الجانبية، يمكنك المساعدة بتوفير معلومات مهمة عن سلامة الدواء.</p><ul dir="rtl"><li>المملكة العربية السعودية</li></ul><p dir="RTL">المركز الوطني للتيقظ الدوائي<br />مركز الاتصال الموحد: 19999<br />البريد الإلكتروني: npc.drug@sfda.gov.sa<br />الموقع الإلكتروني: &nbsp;https://ade.sfda.gov.sa</p><ul dir="rtl"><li>دول الخليج العربي الأخرى</li></ul><p dir="RTL">الرجاء الاتصال بالجهات الوطنية في كل دولة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تمت مراجعة هذه النشرة بتاريخ 10/2023، رقم النسخة SA5.0.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Tekam 200 mg/ 20 ml Solution for Injection/Infusion
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 20 ml of Tekam 200 mg/20 ml Solution for Injection/Infusion contains 230.6 mg ketamine hydrochloride equivalent to 200 mg ketamine.

Excipient with known effect: Sodium

Each 20 ml of Tekam 200 mg/20 ml Solution for Injection/Infusion contains 59.11 mg sodium.

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for Injection/Infusion.

Clear colorless solution.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ketamine is indicated in children and in adults.</p><p>Tekam is recommended:</p><ul><li>As an anaesthetic agent for diagnostic and surgical procedures. When used by intravenous or intramuscular injection, Tekam is best suited for short procedures. With additional doses, or by intravenous infusion, Tekam can be used for longer procedures. If skeletal muscle relaxation is desired, a muscle relaxant should be used and respiration should be supported.</li><li>For the induction of anaesthesia prior to the administration of other general anaesthetic agents.</li><li>To supplement other anaesthetic agents.</li><li>Specific areas of application or types of procedures:</li><li>When the intramuscular route of administration is preferred.</li><li>Debridement, painful dressings, and skin grafting in burned patients, as well as other superficial surgical procedures.</li><li>Neurodiagnostic procedures such as pneumoencephalograms, ventriculograms, myelograms, and lumbar punctures.</li><li>Diagnostic and operative procedures of the eye, ear, nose, and mouth, including dental extractions.</li></ul><p>Note:&nbsp;Eye movements may persist during ophthalmological procedures.</p><ul><li>Anaesthesia in poor-risk patients with depression of vital functions or where depression of vital functions must be avoided, if at all possible.</li><li>Orthopaedic procedures such as closed reductions, manipulations, femoral pinning, amputations, and biopsies.</li><li>Sigmoidoscopy and minor surgery of the anus and rectum, circumcision and pilonidal sinus.</li><li>Cardiac catheterization procedures.</li><li>Caesarean section; as an induction agent in the absence of elevated blood pressure.</li><li>Anaesthesia in the asthmatic patient, either to minimise the risks of an attack of bronchospasm developing, or in the presence of bronchospasm where anaesthesia cannot be delayed.</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For intravenous infusion, intravenous injection or intramuscular injection.</p><p>NOTE: All doses are given in terms of ketamine base</p><p>Adults, elderly (over 65 years) and children:<br />For surgery in elderly patients ketamine has been shown to be suitable either alone or supplemented with other anaesthetic agents.</p><p><strong><em>Preoperative preparations</em></strong><br />Ketamine has been safely used alone when the stomach was not empty. However, since the need for supplemental agents and muscle relaxants cannot be predicted, when preparing for elective surgery it is advisable that nothing be given by mouth for at least six hours prior to anaesthesia.</p><p>Premedication with an anticholinergic agent (e.g. atropine, hyoscine or glycopyrolate) or another drying agent should be given at an appropriate interval prior to induction to reduce ketamine-induced hypersalivation.</p><p>Midazolam, diazepam, lorazepam, or flunitrazepam used as a premedicant or as an adjunct to ketamine, have been effective in reducing the incidence of emergence reactions.</p><p><strong><em>Onset and duration</em></strong><br />As with other general anaesthetic agents, the individual response to ketamine is somewhat varied depending on the dose, route of administration, age of patient, and concomitant use of other agents, so that dosage recommendation cannot be absolutely fixed. The dose should be titrated against the patient&#39;s requirements.</p><p>Because of rapid induction following intravenous injection, the patient should be in a supported position during administration. An intravenous dose of 2 mg/kg of bodyweight usually produces surgical anaesthesia within 30 seconds after injection and the anaesthetic effect usually lasts 5 to 10 minutes. An intramuscular dose of 10 mg/kg of bodyweight usually produces surgical anaesthesia within 3 to 4 minutes following injection and the anaesthetic effect usually lasts 12 to 25 minutes. Return to consciousness is gradual.</p><ul><li><strong><em>Tekam as the sole anaesthetic agent</em></strong></li></ul><p><strong>Intravenous Infusion</strong><br />The use of Tekam by continuous infusion enables the dose to be titrated more closely, thereby reducing the amount of drug administered compared with intermittent administration. This results in a shorter recovery time and better stability of vital signs.</p><p>A solution containing 1 mg/ml of ketamine in dextrose 5% or sodium chloride 0.9% is suitable for administration by infusion.</p><p><u>General Anaesthesia Induction</u><br />An infusion corresponding to 0.5 &ndash; 2 mg/kg as total induction dose.</p><p><u>Maintenance of anaesthesia</u><br />Anaesthesia may be maintained using a microdrip infusion of 10 - 45 microgram/kg/min (approximately 1 &ndash; 3 mg/min).</p><p>The rate of infusion will depend on the patient&#39;s reaction and response to anaesthesia. The dosage required may be reduced when a long acting neuromuscular blocking agent is used.</p><p><strong>Intermittent injection</strong><br /><u>Induction</u><br /><em>Intravenous Route</em><br />The initial dose of Tekam administered intravenously may range from 1 mg/kg to 4.5 mg/kg (in terms of ketamine base). The average amount required to produce 5 to 10 minutes of surgical anaesthesia has been 2.0 mg/kg. It is recommended that intravenous administration be accomplished slowly (over a period of 60 seconds). More rapid administration may result in respiratory depression and enhanced pressor response.</p><p><strong>Dosage in Obstetrics</strong><br />In obstetrics, for vaginal delivery or in caesarean section, intravenous doses ranging from 0.2 to 1.0 mg/kg are recommended (see section 4.6 Fertility, pregnancy and lactation).</p><p><strong>Intramuscular route</strong><br />The initial dose of Tekam administered intramuscularly may range from 6.5 mg/kg to 13 mg/kg (in terms of ketamine base). A low initial intramuscular dose of 4 mg/kg has been used in diagnostic manoeuvres and procedures not involving intensely painful stimuli. A dose of 10 mg/kg will usually produce 12 to 25 minutes of surgical anaesthesia.</p><p><em>Dosage in hepatic insufficiency</em><br />Dose reductions should be considered in patients with cirrhosis or other types of liver impairment (see section 4.4 Special Warnings and Special Precautions for Use).</p><p><strong>Dosage in Obstetrics</strong><br />Data are lacking for intramuscular injection and maintenance infusion of ketamine in the parturient population, and recommendations cannot be made. Available data are presented in Section 5.2.</p><p><strong><em>Maintenance of general anaesthesia</em></strong><br />Lightening of anaesthesia may be indicated by nystagmus, movements in response to stimulation, and vocalization. Anaesthesia is maintained by the administration of additional doses of Tekam by either the intravenous or intramuscular route.</p><p>Each additional dose is from &frac12; to the full induction dose recommended above for the route selected for maintenance, regardless of the route used for induction.</p><p>The larger the total amount of ketamine administered, the longer will be the time to complete recovery.</p><p>Purposeless and tonic-clonic movements of extremities may occur during the course of anaesthesia. These movements do not imply a light plane and are not indicative of the need for additional doses of the anaesthetic.</p><ul><li><strong><em>Tekam as induction agent prior to the use of other general anaesthetics</em></strong></li></ul><p>Induction is accomplished by a full intravenous or intramuscular dose of Tekam as defined above. If Tekam has been administered intravenously and the principal anaesthetic is slow-acting, a second dose of Tekam may be required 5 to 8 minutes following the initial dose. If Tekam has been administered intramuscularly and the principal anaesthetic is rapid-acting, administration of the principal anaesthetic may be delayed up to 15 minutes following the injection of Tekam.</p><ul><li><strong><em>Tekam as supplement to anaesthetic agents</em></strong></li></ul><p>Ketamine is clinically compatible with the commonly used general and local anaesthetic agents when an adequate respiratory exchange is maintained. The dose of Tekam for use in conjunction with other anaesthetic agents is usually in the same range as the dosage stated above; however, the use of another anaesthetic agent may allow a reduction in the dose of Tekam.</p><ul><li><strong><em>Management of patients in recovery</em></strong></li></ul><p>Following the procedure, the patient should be observed but left undisturbed. This does not preclude the monitoring of vital signs. If, during the recovery, the patient shows any indication of emergence delirium, consideration may be given to the use of diazepam (5 to 10 mg I.V. in an adult). A hypnotic dose of a thiobarbiturate (50 to 100 mg I.V.) may be used to terminate severe emergence reactions. If any one of these agents is employed, the patient may experience a longer recovery period.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

Tekam is contra-indicated in persons in whom an elevation of blood pressure would constitute a serious hazard (see section 4.8 Undesirable effects).

Tekam should not be used in patients with eclampsia or pre-eclampsia, severe coronary or myocardial disease, cerebrovascular accident or cerebral trauma.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>To be used only in hospitals by or under the supervision of experienced medically qualified anaesthetists except under emergency conditions.</p><p>As with any general anaesthetic agent, resuscitative equipment should be available and ready for use.</p><p>Respiratory depression may occur with overdosage of ketamine, in which case supportive ventilation should be employed. Mechanical support of respiration is preferred to the administration of analeptics.</p><p>The intravenous dose should be administered over a period of 60 seconds. More rapid administration may result in transient respiratory depression or apnoea and enhanced pressor response.</p><p>Because pharyngeal and laryngeal reflexes usually remain active, mechanical stimulation of the pharynx should be avoided unless muscle relaxants, with proper attention to respiration, are used.</p><p>Although aspiration of contrast medium has been reported during ketamine anaesthesia under experimental conditions (Taylor, P A and Towey, R M, Brit. Med. J. 1971, 2: 688), in clinical practice aspiration is seldom a problem.</p><p>In surgical procedures involving visceral pain pathways, ketamine should be supplemented with an agent which obtunds visceral pain.</p><p>When Tekam is used on an outpatient basis, the patient should not be released until recovery from anaesthesia is complete and then should be accompanied by a responsible adult.</p><p>Tekam should be used with caution in patients with the following conditions:</p><ul><li>Use with caution in the chronic alcoholic and the acutely alcohol-intoxicated patient.</li><li>Ketamine is metabolised in the liver and hepatic clearance is required for termination of clinical effects. A prolonged duration of action may occur in patients with cirrhosis or other types of liver impairment. Dose reductions should be considered in these patients. Abnormal liver function tests associated with ketamine use have been reported, particularly with extended use (&gt;3 days) or drug abuse.</li><li>Since an increase in cerebrospinal fluid (CSF) pressure has been reported during ketamine anaesthesia, Ketamine should be used with special caution in patients with preanaesthetic elevated cerebrospinal fluid pressure.</li><li>Use with caution in patients with globe injuries and increased intraocular pressure (e.g. glaucoma) because the pressure may increase significantly after a single dose of ketamine.</li><li>Use with caution in patients with neurotic traits or psychiatric illness (e.g. schizophrenia and acute psychosis).</li><li>Use in caution in patients with acute intermittent porphyria.</li><li>Use in caution in patients with seizures.</li><li>Use in caution in patients with hyperthyroidism or patients receiving thyroid replacement (increased risk of hypertension and tachycardia).</li><li>Use in caution in patients with pulmonary or upper respiratory infection (ketamine sensitises the gag reflex, potentially causing laryngospasm).</li><li>Use in caution in patients with intracranial mass lesions, a presence of head injury, or hydrocephalus.</li></ul><p><strong><em>Emergence Reaction</em></strong><br />The psychological manifestations vary in severity between pleasant dream-like states, vivid imagery, hallucinations, nightmares and emergence delirium (often consisting of dissociative or floating sensations). In some cases these states have been accompanied by confusion, excitement, and irrational behaviour which a few patients recall as an unpleasant experience (See section 4.8 Undesirable Effects).</p><p>Emergence delirium phenomena may occur during the recovery period. The incidence of these reactions may be reduced if verbal and tactile stimulation of the patient is minimised during the recovery period. This does not preclude the monitoring of vital signs.</p><p><strong><em>Cardiovascular</em></strong><br />Because of the substantial increase in myocardial oxygen consumption, ketamine should be used in caution in patients with hypovolemia, dehydration or cardiac disease, especially coronary artery disease (e.g. congestive heart failure, myocardial ischemia and myocardial infarction). In addition ketamine should be used with caution in patients with mild-to-moderate hypertension and tachyarrhythmias.</p><p>Cardiac function should be continually monitored during the procedure in patients found to have hypertension or cardiac decompensation.</p><p>Elevation of blood pressure begins shortly after the injection of ketamine, reaches a maximum within a few minutes and usually returns to preanaesthetic values within 15 minutes after injection. The median peak rise of blood pressure in clinical studies has ranged from 20 to 25 percent of preanaesthetic values. Depending on the condition of the patient, this elevation of blood pressure may be considered a beneficial effect, or in others, an adverse reaction.</p><p><strong><em>Long-Term Use</em></strong><br />Cases of cystitis, including haemorrhagic cystitis, acute kidney injury, hydronephrosis, and ureteral disorders have been reported in patients being given ketamine on a long term basis, especially in the setting of ketamine abuse. (These adverse reactions develop in patients receiving long term ketamine treatment after a time ranging from 1 month to several years).&nbsp;Ketamine is not indicated nor recommended for long term use.</p><p>Hepatotoxicity has also been reported in patients with extended use (&gt; 3 days).</p><p><strong><em>Drug Abuse and Dependence</em></strong><br />Ketamine has been reported as being a drug of abuse. Reports suggest that ketamine produces a variety of symptoms including, but not limited to, flashbacks, hallucinations, dysphoria, anxiety, insomnia, or disorientation. Adverse effects have also been reported: see &ldquo;Long-Term Use&rdquo;.</p><p>Ketamine dependence and tolerance may develop in individuals with a history of drug abuse or dependence. Therefore, ketamine should be prescribed and administered with caution.</p><p><strong><em>Drug-Induced Liver Injury</em></strong><br />Ketamine administration is associated with hepatobiliary dysfunction (most often a cholestatic pattern), with recurrent use (e.g., misuse/abuse or medically supervised unapproved indications). Biliary duct dilatation with or without evidence of biliary obstruction has also been reported with recurrent use. Obtain baseline LFTs, including alkaline phosphatase and gamma glutamyl transferase, in patients receiving ketamine as part of a treatment plan that utilizes recurrent dosing. Monitor those receiving recurrent ketamine at periodic intervals during treatment.</p><p><strong><em>Tekam contains sodium</em></strong><br />Tekam contains sodium. Each 20 ml of Tekam 200 mg/20 ml Solution for Injection/Infusion contains 59.11 mg sodium (main component of cooking/table salt). This is equivalent to 2.95% of the recommended maximum daily dietary intake of sodium for an adult.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Prolonged recovery time may occur if barbiturates and/or narcotics are used concurrently with ketamine.</p><p>Diazepam is known to increase the half-life of ketamine and prolongs its pharmacodynamic effects. Dose adjustments may therefore be needed.</p><p>Ketamine is chemically incompatible with barbiturates and diazepam because of precipitate formation. Therefore, these should not be mixed in the same syringe or infusion fluid.</p><p>Ketamine may potentiate the neuromuscular blocking effects of atracurium and tubocurarine including respiratory depression with apnoea.</p><p>The use of halogenated anaesthetics concomitantly with ketamine can lengthen the elimination half-life of ketamine and delay recovery from anaesthesia. Concurrent use of ketamine (especially in high doses or when rapidly administered) with halogenated anaesthetics can increase the risk of developing bradycardia, hypotension or decreased cardiac output.</p><p>The use of ketamine with other central nervous system (CNS) depressants (e.g. ethanol, phenothiazines, sedating H<sub>1&nbsp;</sub>&ndash; blockers or skeletal muscle relaxants) can potentiate CNS depression and/or increase risk of developing respiratory depression. Reduced doses of ketamine may be required with concurrent administration of other anxiolytics, sedatives and hypnotics.</p><p>Ketamine has been reported to antagonise the hypnotic effect of thiopental.</p><p>Patients taking thyroid hormones have an increased risk of developing hypertension and tachycardia when given ketamine.</p><p>Concomitant use of antihypertensive agents and ketamine increases the risk of developing hypotension.</p><p>Sympathomimetics (directly or indirectly acting) and vasopressin may enhance the sympathomimetic effects of ketamine.</p><p>Concomitant use with ergometrine may lead to an increase in blood pressure.</p><p>When ketamine and theophylline or aminophylline are given concurrently, a clinically significant reduction in the seizure threshold may be observed. Unpredictable extensor-type seizures have been reported with concurrent administration of these agents.</p><p>Drugs that inhibit CYP3A4 enzyme activity generally decrease hepatic clearance, resulting in increased plasma concentration of CYP3A4 substrate medications, such as ketamine. Coadministration of ketamine with drugs that inhibit CYP3A4 enzyme may require a decrease in ketamine dosage to achieve the desired clinical outcome.</p><p>Drugs that induce CYP3A4 enzyme activity generally increase hepatic clearance, resulting in decreased plasma concentration of CYP3A4 substrate medications, such as ketamine. Coadministration of ketamine with drugs that induce CYP3A4 enzyme may require an increase in ketamine dosage to achieve the desired clinical outcome.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pregnancy</strong><br />Tekam crosses the placenta. This should be borne in mind during operative obstetric procedures in pregnancy. No controlled clinical studies in pregnancy have been conducted. The use in pregnancy has not been established, and such use is not recommended, with the exception of administration during surgery for abdominal delivery or vaginal delivery.</p><p>Some neonates exposed to ketamine at maternal intravenous doses &ge; 1.5 mg/kg during delivery have experienced respiratory depression and low Apgar scores requiring newborn resuscitation.<br />Marked increases in maternal blood pressure and uterine tone have been observed at intravenous doses greater than 2 mg/kg.</p><p>Data are lacking for intramuscular injection and maintenance infusion of ketamine in the parturient population, and recommendations cannot be made. Available data are presented in Section 5.2.</p><p><strong>Lactation</strong><br />The safe use of ketamine during lactation has not been established, and such use is not recommended.</p><p><strong>Fertility</strong><br />Studies in animals have shown reproductive toxicity (see section 5.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Patients should be cautioned that driving a car, operating hazardous machinery or engaging in hazardous activities should not be undertaken for 24 hours or more after anaesthesia.</p><p>This medicine can impair cognitive function and can affect a patient&#39;s ability to drive safely. This class of medicine is in the list of drugs included in regulations under 5a of the Road Traffic Act 1988. When prescribing this medicine, patients should be told:</p><ul><li>The medicine is likely to affect your ability to drive</li><li>Do not drive until you know how the medicine affects you</li><li>It is an offence to drive while under the influence of this medicine</li><li>However, you would not be committing an offence (called &#39;statutory defence&#39;) if:<ul><li>The medicine has been prescribed to treat a medical or dental problem and</li><li>You have taken it according to the instructions given by the prescriber and in the information provided with the medicine and</li><li>It was not affecting your ability to drive safely</li></ul></li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following Adverse Events have been reported:</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td><p><strong>MedDRA System Organ Class</strong></p></td><td><p><strong>Frequency&dagger;</strong></p></td><td><p><strong>Undesirable Effects</strong></p></td></tr><tr><td style="vertical-align:top"><p><strong>Immune system disorders</strong></p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Anaphylactic reaction*</p></td></tr><tr><td style="vertical-align:top"><p><strong>Metabolism and nutrition disorders</strong></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Anorexia</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><strong>Psychiatric disorders</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Hallucination, Abnormal dreams, Nightmare, Confusion, Agitation, Abnormal behaviour</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Anxiety</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Delirium* Disorientation* Flashback*, Dysphoria*, Insomnia,</p></td></tr><tr><td style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Nystagmus, Hypertonia, Tonic clonic movements</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Eye disorders</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Diplopia</p></td></tr><tr><td style="vertical-align:top"><p>Not Known</p></td><td style="vertical-align:top"><p>Intraocular pressure increased</p></td></tr><tr><td rowspan="2" style="vertical-align:top"><p><strong>Cardiac disorders</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Blood pressure increased, Heart rate increased</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Bradycardia, Arrhythmia</p></td></tr><tr><td style="vertical-align:top"><p><strong>Vascular disorders</strong></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Hypotension</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Respiratory rate increased</p></td></tr><tr><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Respiratory depression, Laryngospasm</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Obstructive airway disorder*, Apnoea*</p></td></tr><tr><td rowspan="3" style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Nausea, Vomiting</p></td></tr><tr><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Salivary hypersecretion*</p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Biliary duct dilatation</p></td></tr><tr><td style="vertical-align:top"><p><strong>Hepatobiliary disorders</strong></p></td><td style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Liver function test abnormal, Drug-induced liver injury**, Hepatobiliary dysfunction and biliary duct dilatation</p></td></tr><tr><td style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders</strong></p></td><td style="vertical-align:top"><p>Common</p></td><td style="vertical-align:top"><p>Erythema, Rash morbilliform</p></td></tr><tr><td style="vertical-align:top"><p><strong>Renal and urinary disorders</strong></p></td><td style="vertical-align:top"><p>Rare</p></td><td style="vertical-align:top"><p>Cystitis*, Haemorrhagic cystitis*</p></td></tr><tr><td style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td><td style="vertical-align:top"><p>Uncommon</p></td><td style="vertical-align:top"><p>Injection site pain, Injection site rash</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>&dagger;&nbsp;Common (&ge;1/100 to &lt;1/10); Uncommon (&ge;1/1,000 to &lt;1/100); Rare (&ge;1/10,000 to &lt;1/1,000); Not known (frequency cannot be estimated from the available data)</p><p>* AE frequency estimated from post-marketing safety database</p><p>** Extended period use (&gt; 3 days) or drug abuse</p></td></tr></tbody></table><p><strong>Reporting of suspected adverse reactions</strong><br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via:</p><ul><li>Saudi Arabia</li></ul><p>The National Pharmacovigilance Centre (NPC)<br />SFDA Call Center: 19999<br />E-mail: npc.drug@sfda.gov.sa<br />Website: https://ade.sfda.gov.sa</p><ul><li>Other GCC States</li></ul><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Respiratory depression can result from an overdosage of ketamine hydrochloride. Supportive ventilation should be employed. Mechanical support of respiration that will maintain adequate blood oxygen saturation and carbon dioxide elimination is preferred to administration of analeptics.</p><p>Ketamine has a wide margin of safety; several instances of unintentional administration of overdoses of ketamine (up to 10 times that usually required) have been followed by prolonged but complete recovery.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ATC Code: N01AX03, Pharmacotherapeutic group: Other general anaesthetics.</p><p><strong>Mechanism of Action:</strong><br />Ketamine is a rapidly acting general anaesthetic for intravenous or intramuscular use with a distinct pharmacological action. Ketamine hydrochloride produces dissociative anaesthesia characterised by catalepsy, amnesia, and marked analgesia which may persist&nbsp; into the recovery period. Pharyngeal-laryngeal reflexes remain normal and skeletal muscle tone may be normal or can be enhanced to varying degrees. Mild cardiac and respiratory stimulation and occasionally respiratory depression occur.</p><p>Ketamine induces sedation, immobility, amnesia and marked analgesia. The anaesthetic state produced by ketamine has been termed &ldquo;dissociative anaesthesia&rdquo; in that it appears to selectively interrupt association pathways of the brain before producing somesthetic sensory blockade. It may selectively depress the thalamoneocortical system before significantly obtunding the more ancient cerebral centres and pathways (reticular-activating and limbic systems). Numerous theories have been proposed to explain the effects of ketamine, including binding to N-methyl-D-aspartate (NMDA) receptors in the CNS, interactions with opiate receptors at central and spinal sites and interaction with norepinephrine, serotonin and muscarinic cholinergic receptors. The activity on NMDA receptors may be responsible for the analgesic as well as psychiatric (psychosis) effects of ketamine. Ketamine has sympathomimetic activity resulting in tachycardia, hypertension, increased myocardial and cerebral oxygen consumption, increased cerebral blood flow and increased intracranial and intraocular pressure. Ketamine is also a potent bronchodilator. Clinical effects observed following ketamine administration include increased blood pressure, increased muscle tone (may resemble catatonia), opening of eyes (usually accompanied by nystagmus) and increased myocardial oxygen consumption.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Absorption</strong><br />Ketamine is rapidly absorbed following intra-muscular administration.</p><p><strong>Distribution</strong><br />Ketamine is rapidly distributed into perfused tissues including brain and placenta. Animal studies have shown ketamine to be highly concentrated in body fat, liver and lung. In humans at an intravenous bolus dose of 2.5 mg/kg, the distribution phase of ketamine lasts about 45 minutes, with a half-life of 10 to 15 minutes, which is associated with the duration of the anaesthetic effect (about 20 minutes). Plasma ketamine concentrations are about 1.8 to 2.0 &mu;g/ml at 5 minutes after an intravenous bolus injection of 2 mg/kg dose, and about 1.7 to 2.2 &mu;g/ml at 15 minutes after an intramuscular injection of 6 mg/kg dose in adults and children.</p><p>In parturients receiving an intramuscular dose of 250 mg (approximately 4.2 mg/kg), placental transfer rate of ketamine from maternal artery to umbilical vein was 47% at the time of delivery (1.72 versus 0.75 &micro;g/ml). Average delivery time for these parturients was 12 minutes from the time of ketamine injection to vaginal delivery of a newborn.</p><p><strong>Biotransformation</strong><br />Biotransformation takes place in liver. Termination of anaesthetic is partly by redistribution from brain to other tissues and partly by metabolism. CYP3A4 enzyme is the primary enzyme responsible for ketamine N-demethylation to norketamine in human liver microsomes; with CYP2B6 and CYP2C9 enzymes as minor contributors.</p><p><strong>Elimination</strong><br />Elimination half-life is approximately 2-3 hours, and excretion renal, mostly as conjugated metabolites.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Published studies in animals (including primates) at doses resulting in light to moderate anaesthesia demonstrate that the use of anaesthetic agents during the period of rapid brain growth or synaptogenesis results in cell loss in the developing brain that can be associated with prolonged cognitive deficiencies. The clinical significance of these nonclinical findings is not known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <ul><li>Benzethonium chloride</li><li>Sodium chloride</li><li>Water for injection</li></ul>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ketamine is chemically incompatible with barbiturates and diazepam because of precipitate formation. Therefore, these should not be mixed in the same syringe or infusion fluid.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                36 months.

For single use only. Discard any unused product at the end of each operating session.

After dilution the solutions should be used immediately.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C. Avoid freeze.</p><p>Store in the original package in order to protect from light.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>20 ml amber glass vials sesled with colorless flip-off caps.</p><p><br />Pack size: 10 Vials (20 ml).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>For single use only. Discard any unused product at the end of each operating session.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jazeera Pharmaceutical Industries
Al-Kharj Road 
P.O. Box 106229
Riyadh 11666, Saudi Arabia
Tel: + (966-11) 8107023, + (966-11) 2142472
Fax: + (966-11) 2078170
e-mail: SAPV@hikma.com

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                01 October 2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>